Early response rates with adjunctive cenobamate in uncontrolled focal seizures: Prospective analysis of a randomized, double‐blind, placebo‐controlled study in a multinational Asian population

Statistically significant responses to cenobamate treatment occurred within the first 8 weeks of titration, including a 42.9% median reduction in 28-day seizure frequency (Weeks 5-6) and a seizure-free rate of 26.7% (Weeks 7-8). These data show that substantial seizure reductions occurred in many patients early during cenobamate titration.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2025-11-13
DOI
https://doi.org/10.1111/epi.70012
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early response rates with adjunctive cenobamate in uncontrolled focal seizures: Prospective analysis of a randomized, double‐blind, placebo‐controlled study in a multinational Asian population

Huiqin Xu, Julien Jung, Sunita N. Misra, Takamichi Yamamoto et al.
Epilepsia
Epilepsy research and treatment
article

Early response rates with adjunctive cenobamate in uncontrolled focal seizures: Prospective analysis of a randomized, double‐blind, placebo‐controlled study in a multinational Asian population

Huiqin Xu, Julien Jung, Sunita N. Misra, Takamichi Yamamoto, Louis Ferrari, Myung Won Kim, William E. Rosenfeld, Marc Kamin, Eun-Yeong Choe, Jungshin Park, Huapin Huang, Seung Bong Hong, Pranoti Pradhan, Kyoung Heo, Ji Hyun Kim, Kensuke Kawai, Sang Kun Lee, Songqing Pan, Yong Heui Jeon, Koji Iida
article en

Abstract

Statistically significant responses to cenobamate treatment occurred within the first 8 weeks of titration, including a 42.9% median reduction in 28-day seizure frequency (Weeks 5-6) and a seizure-free rate of 26.7% (Weeks 7-8). These data show that substantial seizure reductions occurred in many patients early during cenobamate titration.

EpilepsiaVol. 67(3)
Fujian Medical University (CN), Seoul National University (KR), Jichi Medical University (JP), Yonsei University (KR), Wenzhou Medical University (CN), Korea University Medical Center (KR), First Affiliated Hospital of Wenzhou Medical University (CN), Wuhan University (CN), Hanall Biopharma (South Korea) (KR), Seirei Mikatabara General Hospital (JP), Center for Children (US), SK Life Science (United States) (US), Hiroshima University Hospital (JP), Renmin Hospital of Wuhan University (CN), Korea University (JP), Seoul Sleep Center (KR), Union Hospital (CN)
Openalex Percentile: Top 60%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.